Showing 15 posts of 108 posts found.


Top Ten most popular articles on this week

September 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …


Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows

August 30, 2018
Research and Development MS, brain, ibudilast, neuroscience, research

The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …


Researchers develop anti-nicotine addiction drugs

August 28, 2018
Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university

Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …


Regenerative process could be restored in liver after severe injuries, study shows

August 16, 2018
Research and Development Edinburgh University, liver, mice, research, transplants

Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …


Researchers design new class of drugs to counter cardiovascular disease

August 14, 2018
Manufacturing and Production TMAO, cardiovascular, gut microbe, heart attack, research

Cleveland Clinic researchers have designed a potential new class of drugs that may reduce the risk of cardiovascular disease by …

Letters to doctors reduce opioid prescriptions, study shows

August 10, 2018
Medical Communications OxyContin, USA, fentanyl, opioid, opioid crisis, research, study

A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …


Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 26, 2018
Research and Development Alzheimer's disease, BAN2401, Biodgen, Eisai, phase 2, research

An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …


Researchers develop algorithm able to identify antidepressant suitability

July 18, 2018
Research and Development McLean, algorithm, antidepressants, research

A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm …

Sanofi invests €66m in Chinese R&D hub

July 3, 2018
Manufacturing and Production China, Sanofi, chengdu, development, pharma, research

French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and …


Study reveals antidepressant medication’s action upon brain

February 3, 2017
Medical Communications, Research and Development antidepressants, mental health, research

With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …


UK Government commits to funding EU research projects after Brexit

August 15, 2016
Manufacturing and Production, Research and Development brexit, research

Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …

Sanofi says to co-develop Zika vaccine with US government

July 6, 2016
Research and Development, Sales and Marketing Sanofi, US government, Vaccine, Zika virus, drug development, research

French drugmaker Sanofi (Euronext: SAN) said it will co-develop a Zika vaccine candidate with the US government.  No financial details …


Merck says its Erbitux in combination with Folfox improves outcomes in colorectal cancer

July 4, 2016
Research and Development, Sales and Marketing Cancer, China, ESMO, Merck, colorectal cancer, drug trial, research, study

Merck said late-stage trials for its Erbitux (cetuximab) in combination with Folfox significantly improved progression free survival in metastatic colorectal …

Pfizer to invest about $350 million in China biotech facility, first in Asia

June 29, 2016
Research and Development, Sales and Marketing Biotech Plant, China, Pfizer, research

US pharma giant Pfizer (NYSE: PFE) said it will invest about $350 million for a global biotechnology center in the …

Boehringer Ingelheim says Phase III trials for its Ofev slowed progression of fatal lung disease

June 27, 2016
Research and Development, Sales and Marketing Boehringer Ingelheim, drug trial, idiopathic pulmonary fibrosis, research

German drugmaker Boehringer Ingelheim said late-stage trials for its Ofev (nintedanib) to treat a fatal lung condition slowed progression of …

Latest content